CompoAtlas

Krill Omega Premium 60 softgels

Food supplement declared in France, declaration No 2019-11-906

Krill Omega Premium 60 softgels (PROZIS) is a food supplement declared in France. Status: retiré du marché le 11 August 2023. 1 rule of use applies to its ingredients (limits and warnings).

Brand
PROZIS
Food business operator placing the product on the market
Prozis.Com, S.A.
Status
Retiré du marché le 11 August 2023
Form
Capsule
Daily dose
1 capsule molle
Directions for use
Prendre une capsule molle par jour.
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes

Declaration 215672, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Linum usitatissimum L.Graine (huile)Pression à froid279 mg

Other active ingredients

NamePer day
Huile de Krillnot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Palmitate de rétinyleVitamine A3,000 µg d'équivalent rétinol800 µg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg

Additives

E422

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Contient des crustacés. Si vous allaitez, veuillez consulter un professionnel de santé avant d'utiliser ce produit. Ne pas utiliser ce produit si vous êtes enceinte ou essayez de le devenir. Déconseillé aux femmes ménopausées. Déconseillé aux femmes ayant des antécédents personnels ou familiaux de cancer du sein. Ne pas dépasser la dose journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Linum usitatissimum L.
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 July 2024

  • Huile de Krill
    Read the warning, when it applies and the studies cited

    Krill Oil

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (HC 2009).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 25 September 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : PROZIS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line